{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:08:22Z","timestamp":1777511302622,"version":"3.51.4"},"reference-count":74,"publisher":"Oxford University Press (OUP)","issue":"1107","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives:<\/jats:title>\n                  <jats:p>The purpose of this study is to investigate the dosimetric effect and clinical impact of delivering a focal radiotherapy boost dose to multiparametric MRI (mp-MRI)-defined dominant intraprostatic lesions (DILs) in prostate cancer using proton therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>We retrospectively investigated 36 patients with pre-treatment mp-MRI and CT images who were treated using pencil beam scanning (PBS) proton radiation therapy to the whole prostate. DILs were contoured on co-registered mp-MRIs. Simultaneous integrated boost (SIB) plans using intensity-modulated proton therapy (IMPT) were created based on conventional whole-prostate-irradiation for each patient and optimized with additional DIL coverage goals and urethral constraints. DIL dose coverage and organ-at-risk (OAR) sparing were compared between conventional and SIB plans. Tumor control probability (TCP) and normal tissue complication probability (NTCP) were estimated to evaluate the clinical impact of the SIB plans.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Optimized SIB plans significantly escalated the dose to DILs while meeting OAR constraints. SIB plans were able to achieve 125, 150 and 175% of prescription dose coverage in 74, 54 and 17% of 36 patients, respectively. This was modeled to result in an increase in DIL TCP by 7.3\u201313.3% depending on \u03b1\/\u03b2 and DIL risk level.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>The proposed mp-MRI-guided DIL boost using proton radiation therapy is feasible without violating OAR constraints and demonstrates a potential clinical benefit by improving DIL TCP. This retrospective study suggested the use of IMPT-based DIL SIB may represent a strategy to improve tumor control.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>This study investigated the planning of mp-MRI-guided DIL boost in prostate proton radiation therapy and estimated its clinical impact with respect to TCP and NTCP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20190845","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T15:39:21Z","timestamp":1578325161000},"source":"Crossref","is-referenced-by-count":23,"title":["A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy"],"prefix":"10.1093","volume":"93","author":[{"given":"Tonghe","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology and Winship Cancer Institute, Emory University , Atlanta 30322 , Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pretesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashesh B.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja M.","family":"Langen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2024050215283904100_b1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10147-008-0866-z","article-title":"Current status and perspectives of brachytherapy for prostate cancer","volume":"14","author":"Yoshioka","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"2024050215283904100_b2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4754031","article-title":"Systematic review of focal prostate brachytherapy and the future implementation of image-guided prostate HDR brachytherapy using MR-Ultrasound fusion","volume":"2016","author":"Peach","year":"2016","journal-title":"Prostate Cancer"},{"issue":"2, Supplement","key":"2024050215283904100_b3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0090-4295(02)02395-6","article-title":"National comprehensive cancer network guidelines for the management of prostate cancer","volume":"61","author":"Scherr","year":"2003","journal-title":"Urology"},{"key":"2024050215283904100_b4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2024050215283904100_b5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/jrr\/rrt027","article-title":"The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer","volume":"54","author":"Yoshioka","year":"2013","journal-title":"J Radiat Res"},{"key":"2024050215283904100_b6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5114\/jcb.2018.76881","article-title":"Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy","volume":"10","author":"Chapman","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"2024050215283904100_b7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2018.12.027","article-title":"Impact of a dominant intraprostatic lesion (DIL) boost defined by sextant biopsy in permanent I-125 prostate implants on biochemical disease free survival (bDFS) and toxicity outcomes","volume":"133","author":"Guimond","year":"2019","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(02)01728-4","article-title":"Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens","volume":"60","author":"Wise","year":"2002","journal-title":"Urology"},{"key":"2024050215283904100_b9","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2011.11.030","article-title":"Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? results of a longitudinal MRI and MRSI study","volume":"82","author":"Arrayeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","article-title":"Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial","volume":"8","author":"Dearnaley","year":"2007","journal-title":"Lancet Oncol"},{"key":"2024050215283904100_b11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.radonc.2016.02.004","article-title":"Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. prospective phase II trial","volume":"119","author":"Gomez-Iturriaga","year":"2016","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b12","first-page":"406","article-title":"Prostate stereotactic ablative radiation therapy using volumetric modulated Arc therapy to dominant intraprostatic lesions. International Journal of radiation oncology, biology","volume":"89","author":"Murray","year":"2014","journal-title":"Physics"},{"key":"2024050215283904100_b13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijrobp.2007.09.034","article-title":"Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer","volume":"70","author":"D'Ambrosio","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b14","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190089","article-title":"Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy","volume":"92","author":"Wang","year":"2019","journal-title":"Br J Radiol"},{"key":"2024050215283904100_b15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0360-3016(98)00502-1","article-title":"Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy","volume":"44","author":"Pickett","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b16","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1118\/1.3685586","article-title":"Experimental assessments of intrafractional prostate motion on sequential and simultaneous boost to a dominant intraprostatic lesion","volume":"39","author":"Abdellatif","year":"2012","journal-title":"Med Phys"},{"key":"2024050215283904100_b17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.meddos.2019.01.008","article-title":"Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: a planning feasibility study","volume":"44","author":"Ciabatti","year":"2019","journal-title":"Medical Dosimetry"},{"key":"2024050215283904100_b18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brachy.2013.10.011","article-title":"Multi-Parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study","volume":"13","author":"Mason","year":"2014","journal-title":"Brachytherapy"},{"key":"2024050215283904100_b19","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijrobp.2010.06.050","article-title":"Parameters favorable to Intraprostatic radiation dose escalation in men with localized prostate cancer","volume":"80","author":"Housri","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/153303461000900503","article-title":"A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer","volume":"9","author":"Oermann","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"2024050215283904100_b21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.brachy.2013.03.003","article-title":"A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer","volume":"12","author":"Spratt","year":"2013","journal-title":"Brachytherapy"},{"key":"2024050215283904100_b22","first-page":"715","article-title":"Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. International Journal of radiation oncology, biology","volume":"88","author":"Georg","year":"2014","journal-title":"Physics"},{"key":"2024050215283904100_b23","article-title":"A MR-TRUS registration method for ultrasound-guided prostate interventions","author":"Yang","year":"2015","journal-title":"SPIE Medical Imaging"},{"key":"2024050215283904100_b24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1001\/jama.2012.460","article-title":"Intensity-Modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer","volume":"307","author":"Sheets","year":"2012","journal-title":"JAMA"},{"key":"2024050215283904100_b25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group\/american College of radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"2024050215283904100_b26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.radonc.2015.07.028","article-title":"Feasibility of dominant intraprostatic lesion boosting using advanced photon-, proton- or brachytherapy","volume":"117","author":"Andrzejewski","year":"2015","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13014-015-0522-5","article-title":"Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer","volume":"10","author":"Yeo","year":"2015","journal-title":"Radiat Oncol"},{"key":"2024050215283904100_b28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2013.02.016","article-title":"Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treatment planning comparison","volume":"107","author":"Fellin","year":"2013","journal-title":"Radiother Oncol"},{"key":"2024050215283904100_b29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1748-717X-8-183","article-title":"3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study","volume":"8","author":"Rischke","year":"2013","journal-title":"Radiat Oncol"},{"key":"2024050215283904100_b30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.eururo.2010.12.009","article-title":"Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting","volume":"59","author":"Dickinson","year":"2011","journal-title":"Eur Urol"},{"key":"2024050215283904100_b31","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1586\/era.11.51","article-title":"Pet and PET\/CT in radiation treatment planning for prostate cancer","volume":"11","author":"Pinkawa","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"2024050215283904100_b32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0360-3016(00)00467-3","article-title":"Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality","volume":"47","author":"Ling","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2013.04.027","article-title":"Boosting imaging defined dominant prostatic tumors: a systematic review","volume":"107","author":"Bauman","year":"2013","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.radonc.2018.04.015","article-title":"Contouring of prostate tumors on multiparametric MRI: evaluation of clinical delineations in a multicenter radiotherapy trial","volume":"128","author":"van Schie","year":"2018","journal-title":"Radiother Oncol"},{"key":"2024050215283904100_b35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2017.12.022","article-title":"Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: toxicity in the flame randomized controlled trial","volume":"127","author":"Monninkhof","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13014-018-1036-8","article-title":"Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET\/CT and MRI: a planning study based on histology reference","volume":"13","author":"Zamboglou","year":"2018","journal-title":"Radiation Oncology"},{"key":"2024050215283904100_b37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2008.07.055","article-title":"Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.","volume":"74","author":"Brame","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b38","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2214\/AJR.09.2527","article-title":"Imaging localized prostate cancer: current approaches and new developments","volume":"192","author":"Turkbey","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"2024050215283904100_b39","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III Noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"issue":"Suppl2","key":"2024050215283904100_b40","first-page":"11","article-title":"Tumour control probability modelling: basic principles and applications in treatment planning","volume":"17","author":"Nahum","year":"2001","journal-title":"Physica Medica"},{"key":"2024050215283904100_b41","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(89)90972-3","article-title":"Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method gerald","volume":"16","author":"Kutcher","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: a concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"2024050215283904100_b43","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3576626","article-title":"Complication probability as assessed from Dose-Volume histograms","volume":"104","author":"Lyman","year":"1985","journal-title":"Radiat Res"},{"key":"2024050215283904100_b44","first-page":"1532","article-title":"Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. International Journal of radiation oncology, biology","volume":"73","author":"Fowler","year":"2009","journal-title":"Physics"},{"key":"2024050215283904100_b45","first-page":"507","article-title":"A simple method of obtaining equivalent doses for use in HDR brachytherapy. International Journal of radiation oncology, biology","volume":"46","author":"Nag","year":"2000","journal-title":"Physics"},{"key":"2024050215283904100_b46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1259\/bjr\/20476567","article-title":"Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite","volume":"85","author":"Uzan","year":"2012","journal-title":"Br J Radiol"},{"key":"2024050215283904100_b47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1259\/bjr.75.890.750151","article-title":"Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy","volume":"75","author":"Nutting","year":"2002","journal-title":"Br J Radiol"},{"key":"2024050215283904100_b48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.radonc.2017.04.021","article-title":"Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET\/CT: A planning study based on histopathology reference","volume":"123","author":"Zamboglou","year":"2017","journal-title":"Radiother Oncol"},{"issue":"3 Suppl","key":"2024050215283904100_b49","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"2024050215283904100_b50","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3, Supplement","key":"2024050215283904100_b52","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b53","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1016\/S0167-8140(18)30631-5","article-title":"PV-0321: influence of urethra contouring on Ntcp models predicting urethral strictures in prostate HDRB","volume":"127","author":"Panettieri","year":"2018","journal-title":"Radiotherapy and Oncology"},{"key":"2024050215283904100_b54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/153303460600500203","article-title":"Innovative strategies for image-guided proton treatment of prostate cancer","volume":"5","author":"Schulte","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"2024050215283904100_b55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phro.2018.06.002","article-title":"A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting","volume":"6","author":"Pedersen","year":"2018","journal-title":"Physics and Imaging in Radiation Oncology"},{"key":"2024050215283904100_b56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1748-717X-7-82","article-title":"Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy","volume":"7","author":"Vainshtein","year":"2012","journal-title":"Radiat Oncol"},{"key":"2024050215283904100_b57","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/01.ju.0000035544.25483.61","article-title":"Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland","volume":"169","author":"Merrick","year":"2003","journal-title":"Journal of Urology"},{"key":"2024050215283904100_b58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2016.07.033","article-title":"The price of target dose uniformity","volume":"96","author":"Craft","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b59","first-page":"701","article-title":"Causes and consequences of inhomogeneous dose distributions in radiation therapy. International Journal of radiation oncology, biology","volume":"12","author":"Goitein","year":"1986","journal-title":"Physics"},{"key":"2024050215283904100_b60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/acm2.12424","article-title":"A quantitative assessment of the consequences of allowing dose heterogeneity in prostate radiation therapy planning","volume":"19","author":"Sun","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"2024050215283904100_b61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"2024050215283904100_b62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ijrobp.2010.11.054","article-title":"Long-Term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer","volume":"82","author":"King","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4111\/icu.2016.57.5.309","article-title":"Urethral strictures after radiation therapy for prostate cancer","volume":"57","author":"Moltzahn","year":"2016","journal-title":"Investig Clin Urol"},{"key":"2024050215283904100_b64","first-page":"204","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. International Journal of radiation oncology, biology","volume":"82","author":"Mohammed","year":"2012","journal-title":"Physics"},{"key":"2024050215283904100_b65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1120\/jacmp.v14i1.3882","article-title":"Dosimetric assessment of prostate cancer patients through principal component analysis (PCA","volume":"14","author":"Gloi","year":"2013","journal-title":"Journal of Applied Clinical Medical Physics"},{"key":"2024050215283904100_b66","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3109\/0284186X.2014.986288","article-title":"Anterior-oriented proton beams for prostate cancer: a multi-institutional experience","volume":"54","author":"Cuaron","year":"2015","journal-title":"Acta Oncol"},{"issue":"3 Suppl","key":"2024050215283904100_b67","first-page":"S10","article-title":"Use of normal tissue complication probability models in the clinic. International Journal of radiation oncology, biology","volume":"76","author":"Marks","year":"2010","journal-title":"Physics"},{"issue":"S5","key":"2024050215283904100_b68","doi-asserted-by":"crossref","first-page":"S807","DOI":"10.21037\/tcr.2017.06.03","article-title":"Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: recent trends and current issues","volume":"6","author":"Tommasino","year":"2017","journal-title":"Transl Cancer Res"},{"key":"2024050215283904100_b69","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b70","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mrm.23062","article-title":"DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study","volume":"67","author":"Barrett","year":"2012","journal-title":"Magnetic Resonance in Medicine"},{"key":"2024050215283904100_b71","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ijrobp.2010.02.060","article-title":"Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI","volume":"80","author":"Alonzi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050215283904100_b72","first-page":"8","article-title":"A MRI-CT prostate registration using sparse representation technique","volume":"9786","author":"Yang","year":"2016","journal-title":"SPIE Medical Imaging"},{"key":"2024050215283904100_b73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.media.2015.04.014","article-title":"Robust inverse-consistent affine CT\u2013MR registration in MRI-assisted and MRI-alone prostate radiation therapy","volume":"23","author":"Rivest-H\u00e9nault","year":"2015","journal-title":"Med Image Anal"},{"key":"2024050215283904100_b74","first-page":"244","article-title":"3Rd. forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. International Journal of radiation oncology, biology","volume":"51","author":"Xia","year":"2001","journal-title":"Physics"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1107\/20190845\/57376807\/bjr.20190845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1107\/20190845\/57376807\/bjr.20190845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T16:57:14Z","timestamp":1714669034000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190845\/7449248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":74,"journal-issue":{"issue":"1107","published-online":{"date-parts":[[2020,1,6]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190845","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,1]]},"published":{"date-parts":[[2020,1,6]]},"article-number":"20190845"}}